Psoriasis is an inflammatory epidermal proliferative dermatosis which affects 2%-3% of the world's population. 1 Clinically, psoriasis is characterized by clear boundaries of skin lesions, erythema and scales on the skin. 2 Psoriasis was not initially considered as a disease, but a dysfunction of keratinocytes in the epidermis. 3 A large number of studies have shown that the innate and adaptive immune responses of cells, especially the T-cell-mediated system, play an important role in the pathogenesis of psoriasis. 4 In addition, the cytokine network is a key element in psoriasis. The expression levels of interleukin (IL)-1, tumour necrosis factor (TNF), interleukin-12 (IL-12), interleukin-17 (IL-17), interleukin-22 (IL-22) and interleukin-23 (IL-23) in psoriatic skin are significantly increased. Among them, IL-17A and IL-22 have the most profound effects on keratinocytes. 5 In psoriatic lesions, keratinocytes are activated and proliferate much faster than normal keratinocytes. 6 Not only do cytokines have a strong influence on psoriasis but many immune cells also change greatly in psoriasis. Inflammatory cells in psoriatic skin are mainly composed of dendritic cells (DCs), macrophages, dermal T cells and epidermal neutrophils. 7 Among these immune cells, dendritic cells increase significantly in psoriatic lesions. Although DCs play a central role in the pathogenesis of psoriasis, the specific role of each DC is not clear. At present, it is believed that psoriasis is caused by the imbalance